Ramadan Fasting in Secondary Adrenal Insufficiency Patients
1 other identifier
interventional
63
1 country
1
Brief Summary
Intermittent Ramadan fasting was associated with a risk of complications in patients with adrenal insufficiency. A risk stratification with recommendations (lifestyle and drug adjustment) for fasting in these patients has been recently published. So, this prospective interventional study was carried out to evaluated these recommendations. Patients with secondary adrenal insufficiency and willing to fast Ramadan were included. Before Ramadan, patients underwent a clinical examination and were educated for lifestyle measures and the schedule of glucocorticoid replacement therapy was adjusted. The occurrence of complications and the number of fasted days during the month of Ramadan 2023 were reported and compared with those of Ramadan 2022.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 12, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFebruary 13, 2025
February 1, 2025
10 months
April 12, 2023
February 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
number of fasted days
change in the number of fasted days
one month
prevalence of complications
change in the prevalece of complications
one month
Study Arms (1)
patients with secondary adrenal insufficiency
EXPERIMENTALeducation and treatment adjustment
Interventions
education of the patients (lifestyle) and adjustement of glucocorticoid replacement schedule
Eligibility Criteria
You may qualify if:
- Patients aged over 18 years
- Secondary adrenal insufficiency patients
- Substituted with glucocorticoids for more than one year.
- Willing to fast during the month of Ramadan 2023
You may not qualify if:
- cardiac insufficiency,
- respiratory insufficiency,
- hepatic insufficiency,
- renal insufficiency (creatinine clearance \< 60 ml/min/1.73m2),
- advanced neoplasia,
- undernutrition,
- diabetes insipidus,
- diabetes mellitus,
- neuro-psychiatric disease,
- infectious disease
- chronic inflammatory disease,
- hyperthyroidism,
- uncontrolled hypothyroidism,
- alcoholism,
- diuretic intake,
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital La Rabtalead
Study Sites (1)
University Hospital La Rabta
Tunis, Tunisia
Related Publications (7)
Chihaoui M, Yazidi M, Oueslati I, Khessairi N, Chaker F. Intermittent fasting in adrenal insufficiency patients: a review and guidelines for practice. Endocrine. 2021 Oct;74(1):11-19. doi: 10.1007/s12020-021-02804-z. Epub 2021 Jul 2.
PMID: 34213700BACKGROUNDChihaoui M, Chaker F, Yazidi M, Grira W, Ben Amor Z, Rejeb O, Slimane H. Ramadan fasting in patients with adrenal insufficiency. Endocrine. 2017 Jan;55(1):289-295. doi: 10.1007/s12020-016-1186-0. Epub 2016 Nov 23.
PMID: 27878773BACKGROUNDChihaoui M, Grira W, Bettaieb J, Yazidi M, Chaker F, Rejeb O, Oueslati I, Feki M, Kaabachi N, Slimane H. The risk for hypoglycemia during Ramadan fasting in patients with adrenal insufficiency. Nutrition. 2018 Jan;45:99-103. doi: 10.1016/j.nut.2017.07.014. Epub 2017 Aug 3.
PMID: 29129244BACKGROUNDHussain S, Hussain S, Mohammed R, Meeran K, Ghouri N. Fasting with adrenal insufficiency: Practical guidance for healthcare professionals managing patients on steroids during Ramadan. Clin Endocrinol (Oxf). 2020 Aug;93(2):87-96. doi: 10.1111/cen.14250. Epub 2020 Jun 15.
PMID: 32419166BACKGROUNDChihaoui M, Mimita W, Oueslati I, Rejeb O, Ben Amor Z, Grira W, Yazidi M, Chaker F. Prednisolone or hydrocortisone replacement in patients with corticotrope deficiency fasting during Ramadan result in similar risks of complications and quality of life: a randomized double-blind controlled trial. Endocrine. 2020 Jan;67(1):155-160. doi: 10.1007/s12020-019-02082-w. Epub 2019 Sep 24.
PMID: 31552584BACKGROUNDMabrouk M, Chihaoui M, Sta J, Slimane CB, Oueslati I, Yazidi M, Chaker F. Ramadan Fasting Improves Health-Related Quality of Life in Patients With Secondary Adrenal Insufficiency: A Prospective Interventional Case-Control Study. Clin Endocrinol (Oxf). 2025 Oct;103(4):523-530. doi: 10.1111/cen.15286. Epub 2025 Jun 2.
PMID: 40452492DERIVEDChihaoui M, Mabrouk M, Oueslati I, Khessairi N, Chaker F, Yazidi M. Evaluation of therapeutic education on intermittent fasting in patients with secondary adrenal insufficiency: A clinical trial. Nutrition. 2025 Apr;132:112688. doi: 10.1016/j.nut.2025.112688. Epub 2025 Jan 14.
PMID: 39933257DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 12, 2023
First Posted
April 25, 2023
Study Start
March 1, 2023
Primary Completion
December 30, 2023
Study Completion
March 1, 2024
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- after the publication of this study
Data can be shared on reasonable request.